| Koers | 204.30 | Hoogste koers | 204.30 |
| Laagste koers | 204.30 | 1-jrs rend. | 8.27 |
| Sector | Gezondheid | Subsector | Gezondheidsprodukten / diensten |
Contactinformatie:Land: Frankrijk
| Jaar | Omzet | Totaal omzet sector | Marktaandeel |
|---|---|---|---|
| 2019 | 1,441 | 1,914,856 | 0.08 % |
| 2020 | 1,910 | 1,909,941 | 0.10 % |
| 2021 | 2,887 | 2,244,427 | 0.13 % |
| 2022 | 3,493 | 2,638,646 | 0.13 % |
| 2023 | 2,776 | 2,748,111 | 0.10 % |
| Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
|---|---|---|---|---|---|
| 8 december 2025 | JP Morgan | Sartorius Stedim Biotech SA | Kopen | 260.00 | 21.42 % |
| 4 oktober 2025 | Barclays | Sartorius Stedim Biotech SA | Kopen | 240.00 | 14.88 % |
No Records Found
No Records Found
No Records Found
| Resultaten |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Omzet |
|
|
|
|
|
| Kosten |
|
|
|
|
|
| Nettowinst |
|
|
|
|
|
| Winstmarge |
|
|
|
|
|
| ROI |
|
|
|
|
|
| Balans |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Eigen vermogen |
|
|
|
|
|
| Vreemd vermogen |
|
|
|
|
|
| Totaal vermogen |
|
|
|
|
|
| Solvabiliteit |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Kasstroom |
|
|
|
|
|
| Werknemers |
|
|
|
|
|
| Omzet per werknemer |
|
|
|
|
|
| Kasstroom / vreemd vermogen |
|
|
|
|
|
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Koers |
59.97
|
60.29
|
87.35
|
147.70
|
291.20
|
| Winst per aandeel |
1.67
|
1.75
|
2.26
|
2.54
|
3.64
|
| Koers / winst-verhouding |
35.91
|
34.45
|
38.65
|
58.15
|
56.13
|
| Dividend |
0.42
|
0.46
|
0.57
|
0.34
|
0.68
|
| Dividend % |
0.70 %
|
0.76 %
|
0.65 %
|
0.23 %
|
0.33 %
|
| Payout % |
0.25
|
0.26
|
0.25
|
0.13
|
0.19
|
| Boekwaarde |
8.22
|
9.46
|
11.24
|
12.57
|
15.60
|
| Boek / koers |
0.14
|
0.16
|
0.13
|
0.09
|
0.08
|
| Kasstroom per aandeel |
1.70
|
1.90
|
2.47
|
3.36
|
4.52
|
| Aandelen |
92
|
92
|
92
|
92
|
92
|
| Marktkap. |
5.528,05
|
5.557,54
|
8.051,94
|
13.615,02
|
18.832,41
|
|
Datum
|
Koers
|
|---|---|
|
21 dec
|
204.30
|